being a plant biotechnology company focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. Could cessation, or possibly MJ be next on 'ciggy's agenda. My thoughts would be XXII coming out with stellar N/R's in a rapid fire approach to quell the naysayers that have proved to be so wrong in their futile attempts to stop the company's progress.
COULD THE CHINESE MARKETS BE NEXT? ONE IN THREE SMOKERS ON THE PLANET ARE LOCATED THERE!
The patient waiting for all longs is now over imo!!
News 
Market Data 
Discover 
